Most Effective Colon Cancer Chemopreventive Agents in Rats: A Systematic Review of Aberrant Crypt Foci and Tumor Data, Ranked by Potency, Nutrition and Cancer, vol.43, issue.1, pp.1-421, 2002. ,
DOI : 10.1207/S15327914NC431_1
URL : https://hal.archives-ouvertes.fr/hal-00284366
Rationale and prospects for the use of cyclooxygenase-2 (COX-2) inhibitors in colorectal cancer, Gastroenterol Clin Biol, vol.25, pp.967-978, 2001. ,
A Hypothesis: Nonsteroidal Anti-Inflammatory Drugs Reduce the Incidence of Large-Bowel Cancer, JNCI Journal of the National Cancer Institute, vol.83, issue.5, pp.355-358, 1991. ,
DOI : 10.1093/jnci/83.5.355
NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, EICOSANOIDS, AND COLORECTAL CANCER PREVENTION, Gastroenterology Clinics of North America, vol.25, issue.4, pp.773-791, 1996. ,
DOI : 10.1016/S0889-8553(05)70274-0
Aspirin and nonsteroidal anti-inflammatory agents and risk for colorectal adenomas, Gastroenterology, vol.114, issue.3, pp.441-447, 1998. ,
DOI : 10.1016/S0016-5085(98)70526-8
Cyclooxygenase in biology and disease, FASEB J, vol.12, pp.1063-1073, 1998. ,
Why there are two cyclooxygenase isozymes, Journal of Clinical Investigation, vol.107, issue.12, pp.1491-1495, 2001. ,
DOI : 10.1172/JCI13271
Cyclooxygenases: Structural, Cellular, and Molecular Biology, Annual Review of Biochemistry, vol.69, issue.1, pp.145-182, 2000. ,
DOI : 10.1146/annurev.biochem.69.1.145
Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas, Gastroenterology, vol.107, issue.4, pp.1183-1188, 1994. ,
DOI : 10.1016/0016-5085(94)90246-1
Expression of cyclooxygenase-1 and -2 in human colorectal cancer, Cancer Res, vol.55, pp.3785-3789, 1995. ,
Reduced COX-2 protein in colorectal cancer with defective mismatch repair, Cancer Res, vol.58, pp.5473-5477, 1998. ,
Coordinate regulation of cyclooxygenase-2 and TGF-1 in replication error-positive colon cancer and azoxymethane-induced rat colonic tumors, Carcinogenesis, vol.20, issue.2, pp.185-191, 1999. ,
DOI : 10.1093/carcin/20.2.185
Cyclooxygenase-2 overexpression and tumor formation are blocked by sulindac in a murine model of familial adenomatous polyposis, Cancer Res, vol.56, pp.2556-2560, 1996. ,
Altered eicosanoid levels in human colon cancer, J Lab Clin Med, vol.122, pp.518-523, 1993. ,
Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2, Cell, vol.83, issue.3, pp.493-501, 1995. ,
DOI : 10.1016/0092-8674(95)90127-2
Overexpression of Cyclooxygenase-2 Is Sufficient to Induce Tumorigenesis in Transgenic Mice, Journal of Biological Chemistry, vol.276, issue.21, pp.18563-18569, 2001. ,
DOI : 10.1074/jbc.M010787200
Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: A full in vitro analysis, Proceedings of the National Academy of Sciences, vol.33, issue.5753, pp.7563-7568, 1999. ,
DOI : 10.1038/284271a0
Effect of sulindac on small polyps in familial adenomatous polyposis, The Lancet, vol.345, issue.8953, pp.855-856, 1995. ,
DOI : 10.1016/S0140-6736(95)92989-4
The Effect of Celecoxib, a Cyclooxygenase-2 Inhibitor, in Familial Adenomatous Polyposis, New England Journal of Medicine, vol.342, issue.26, pp.1946-1952, 2000. ,
DOI : 10.1056/NEJM200006293422603
A randomised, double blind, placebo controlled study of celecoxib, a selective cyclooxygenase 2 inhibitor, on duodenal polyposis in familial adenomatous polyposis, Gut, vol.50, issue.6, pp.857-860, 2002. ,
DOI : 10.1136/gut.50.6.857
Long-term treatment with sulindac in familial adenomatous polyposis: A prospective cohort study, Gastroenterology, vol.122, issue.3, pp.641-645, 2002. ,
DOI : 10.1053/gast.2002.31890
Evaluation of cyclooxygenase-2 inhibitor for potential chemopreventive properties in colon carcinogenesis, Cancer Res, vol.56, pp.4566-4569, 1996. ,
Chemopreventive activity of celecoxib, a 354 B. Buecher et al. specific cyclooxygenase-2 inhibitor, against colon carcinogenesis, Cancer Res, vol.58, pp.409-412, 1998. ,
EPIDEMIOLOGY AND RISK FACTORS FOR COLORECTAL CANCER, Gastroenterology Clinics of North America, vol.25, issue.4, pp.717-735, 1996. ,
DOI : 10.1016/S0889-8553(05)70271-5
Possible relationships between bowel cancer and dietary habits, Proc R Soc Med, vol.64, pp.964-965, 1971. ,
Dietary Fiber and the Risk of Colorectal Cancer and Adenoma in Women, New England Journal of Medicine, vol.340, issue.3, pp.169-176, 1999. ,
DOI : 10.1056/NEJM199901213400301
Lack of Effect of a High-Fiber Cereal Supplement on the Recurrence of Colorectal Adenomas, New England Journal of Medicine, vol.342, issue.16, pp.1156-1162, 2000. ,
DOI : 10.1056/NEJM200004203421602
Calcium and fibre supplementation in prevention of colorectal adenoma recurrence: a randomised intervention trial, The Lancet, vol.356, issue.9238, pp.1300-1306, 2000. ,
DOI : 10.1016/S0140-6736(00)02813-0
Lack of Effect of a Low-Fat, High-Fiber Diet on the Recurrence of Colorectal Adenomas, New England Journal of Medicine, vol.342, issue.16, pp.1149-1155, 2000. ,
DOI : 10.1056/NEJM200004203421601
Dietary fibre in food and protection against colorectal cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC): an observational study, Dietary fibre in food and protection against colorectal cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC): an observational study, pp.1496-1501, 2003. ,
DOI : 10.1016/S0140-6736(03)13174-1
URL : https://hal.archives-ouvertes.fr/inserm-00110132
Dietary fibre and colorectal adenoma in a colorectal cancer early detection programme, The Lancet, vol.361, issue.9368, pp.1491-1495, 2003. ,
DOI : 10.1016/S0140-6736(03)13173-X
Butyrate and trichostatin A effects on the proliferation/differentiation of human intestinal epithelial cells: induction of cyclin D3 and p21 expression, Gut, vol.46, issue.4, pp.507-514, 2000. ,
DOI : 10.1136/gut.46.4.507
Short chain fatty acids and colon cancer, J Nutr, vol.132, pp.3804-3808, 2002. ,
Molecular analysis of the effect of short-chain fatty acids on intestinal cell proliferation, Proceedings of the Nutrition Society, vol.9, issue.01, pp.101-106, 2003. ,
DOI : 10.1128/MCB.20.5.1797-1815.2000
COMPARISON OF THE EFFECT OF DIFFERENT SHORT CHAIN FATTY ACIDS ON THE GROWTH AND DIFFERENTIATION OF HUMAN COLONIC CARCINOMA CELL LINESIN VITRO, Cell Biology International, vol.21, issue.5, pp.281-287, 1997. ,
DOI : 10.1006/cbir.1997.0153
Butyrate inhibits inflammatory responses through NFkappa B inhibition: implications for Crohn's disease, Gut, vol.47, issue.3, pp.397-403, 2000. ,
DOI : 10.1136/gut.47.3.397
Butyrate production from dietary fibre and protection against large bowel cancer in a rat model., Gut, vol.34, issue.3, pp.386-391, 1993. ,
DOI : 10.1136/gut.34.3.386
Only fibres promoting a stable butyrate producing colonic ecosystem decrease the rate of aberrant crypt foci in rats, Gut, vol.48, issue.1, pp.53-61, 2001. ,
DOI : 10.1136/gut.48.1.53
Observation and quantification of aberrant crypts in the murine colon treated with a colon carcinogen: Preliminary findings, Cancer Letters, vol.37, issue.2, pp.147-151, 1987. ,
DOI : 10.1016/0304-3835(87)90157-1
Aberrant crypts correlate with tumor incidence in F344 rats treated with azoxymethane and phytate, Carcinogenesis, vol.13, issue.9, pp.1509-1512, 1992. ,
DOI : 10.1093/carcin/13.9.1509
Characterisation of aberrant crypt foci in carcinogen-treated rats: association with intestinal carcinogenesis, British Journal of Cancer, vol.71, issue.4, pp.763-769, 1995. ,
DOI : 10.1038/bjc.1995.148
Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2, Nature Reviews Cancer, vol.1, issue.1, pp.11-21, 2001. ,
DOI : 10.1038/35094017
Suppression of Occurrence and Advancement of ??-Catenin-accumulated Crypts, Possible Premalignant Lesions of Colon Cancer, by Selective Cyclooxygenase-2 Inhibitor, Celecoxib, Japanese Journal of Cancer Research, vol.109, issue.6, pp.617-623, 2001. ,
DOI : 10.1111/j.1349-7006.2001.tb01139.x
Chemoprevention of colon cancer by specific cyclo- oxygenase-2 inhibitor ,
Non-steroidal anti-inflammatory drugs with different cyclooxygenase inhibitory profiles that prevent aberrant crypt foci formation but vary in acute gastrotoxicity in a rat model, Journal of Gastroenterology and Hepatology, vol.52, issue.12, pp.1386-1392, 2000. ,
DOI : 10.1046/j.1440-1746.2000.02370.x
Short-chain fatty acids and human colonic function: roles of resistant starch and nonstarch polysaccharides, Physiol Rev, vol.81, pp.1031-1064, 2001. ,
Prolonged intake of fructo-oligosaccharides induces a short-term elevation of lactic acid-producing bacteria and a persistent increase in cecal butyrate in rats, J Nutr, vol.129, pp.2231-2235, 1999. ,
Effect of dietary oligofructose and inulin on colonic preneoplastic aberrant crypt foci inhibition, Carcinogenesis, vol.18, issue.7, pp.1371-1374, 1997. ,
DOI : 10.1093/carcin/18.7.1371
A comparison of the effects of dietary cellulose and fermentable galacto-oligosaccharide, in a rat model of colorectal carcinogenesis: fermentable fibre confers greater protection than non-fermentable fibre in both high and low fat backgrounds, Carcinogenesis, vol.20, issue.4, pp.651-656, 1999. ,
DOI : 10.1093/carcin/20.4.651
Intestinal tumorigenesis in the Apc1638N mouse treated with aspirin and resistant starch for up to 5 months, Carcinogenesis, vol.20, issue.5, pp.805-810, 1999. ,
DOI : 10.1093/carcin/20.5.805
Nonsteroidal Anti-inflammatory Drugs as Anticancer Agents: Mechanistic, Pharmacologic, and Clinical Issues, JNCI Journal of the National Cancer Institute, vol.94, issue.4 ,
DOI : 10.1093/jnci/94.4.252
A cyclooxygenase-2 (COX-2) selective non-steroidal anti-inflammatory drug enhances the growth inhibitory effect of butyrate in colorectal carcinoma cells expressing COX-2 protein: regulation of COX-2 by butyrate, Carcinogenesis, vol.21, issue.1, pp.69-77, 2000. ,
DOI : 10.1093/carcin/21.1.69
Butyrate and aspirin in combination have an enhanced effect on apoptosis in human colorectal cancer cells, European Journal of Cancer Prevention, vol.11, issue.3, pp.271-281, 2002. ,
DOI : 10.1097/00008469-200206000-00011
Diet and cancer prevention: the Concerted Action Polyp Prevention (CAPP) Studies, Proceedings of the Nutrition Society, vol.270, issue.02, pp.183-186, 1998. ,
DOI : 10.1001/archinte.154.4.394